ChemoCentryx, Inc. (CCXI) said Monday that it has completed its initial public offering of 4.5 million shares of common stock.
In addition, the underwriters of the initial public offering exercised their over-allotment option in full and purchased an additional 675,000 shares of common stock.
All of such shares were sold by ChemoCentryx at an initial public offering price of $10.00 per share.
J.P. Morgan and Citigroup acted as joint book-running managers of the offering, and Cowen and Company acted as co-manager of the offering.
Click here to receive FREE breaking news email alerts for NYSE Euronext and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org